Eli Lilly (LLY) Q3 2026 Earnings Call Transcript
On its third-quarter 2026 earnings call, Eli Lilly reported revenue growth of 39%, attributed to demand for its obesity drugs and strong international growth.
fool.com ·
Activos compatibles
Abrir Mo
Eli Lilly
Antes de apertura
1424,48 US$
-en el período seleccionado
+15,09 US$ (+1,07 %)desde el cierre de EE. UU.
- Precio onchain
- -
- Prima / descuento
- -
Actualizado Referencia
Diferencias de precio antes de comisiones y costes de ejecución. Comparar precios
Noticias
Eli Lilly 'merece' subir en bolsa: analista
Benzinga informa que Eli Lilly superó las estimaciones del tercer trimestre gracias al crecimiento de Mounjaro y Zepbound, y que su guía de ingresos para 2026 subió a 92 mil millones de dólares.
benzinga.com ·
LLY Stock Hits Record as CEO Says Middle-Income Consumers Are Driving Pharma’s ‘Largest New Category Expansion’
Eli Lilly CEO David Ricks said middle-income consumers are driving what he called the largest new category expansion in pharma, according to Benzinga's report on the company's latest earnings.
benzinga.com ·
Eli Lilly raised its outlook for a third time this year thanks to soaring Zepbound sales
Eli Lilly raised its revenue guidance to $91 billion to $92 billion from $85 billion to $87 billion, its third outlook increase this year, as quarterly sales climbed 39%.
qz.com ·
Eli Lilly in Charts: Q3 Mounjaro reaches $10.7B, Jardiance surges 64.5% Y/Y to $1.58B
Seeking Alpha reports Mounjaro sales reached $10.7B in the third quarter, while Jardiance rose 64.5% year over year to $1.58B.
seekingalpha.com ·
Token
- Token
- LLYc
- Acciones por token
- 1.00000000 LLY
Consigue Mo
Guárdalo en Mo
Mantén LLYc en una billetera inteligente de Mo en Base que tú controlas.
Muévelo rápido
Envía LLYc a otro usuario de Mo sin comisiones, o a cualquier billetera compatible en Base casi al instante.